MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Nasal septum deviation correlates with asymmetry in Parkinson’s disease

    J. Wang, J. Wang, F. Liu, C. Zuo, Y. Sun, J. Wu (Shanghai, China)

    Objective: To assesse whether asymmetry in the nasal cavity is related to dopaminergic dysfunction asymmetry in PD patients Background: Asymmetry in motor dysfunction and associated dopaminergic…
  • 2025 International Congress

    The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset

    J. Hoenicka, A. Pascual, P. García-Ruíz, X. Castro-Martínez, R. Repossi, O. de Fabregues, L. Vela-Desojo, M. Mata, I. Torres, JC. Martinez-Castrillo, F. Palau, G. Fernandez (Mexico City, Mexico)

    Objective: This work aims to investigate the role of regulatory regions in Parkinson’s disease (PD) genes, which may help explain part of the missing heritability.…
  • 2025 International Congress

    Role of presenilin 1 variants in parkinsonism

    M. Kinoshita, H. Ohara, R. Sasaki, K. Tamura, A. Elangovan, HW. Suresh Babu, S. Muthukumar, M. Iyer, B. Vellingiri (Kyoto, Japan)

    Objective: To characterize presenilin 1 gene (PSEN1) variants which can cause parkinsonism. Background: Variants in PSEN1 are associated with early onset Alzheimer’s disease mainly due…
  • 2025 International Congress

    Parkinsonism after Post-Anoxic Brain Injury

    B. Petko, S. Factor, R. Tripathi (Atlanta, USA)

    Objective: To describe two cases of parkinsonism caused by anoxic brain injury. Background: Movement disorders occur in about 40% of patients following anoxic brain injury,…
  • 2025 International Congress

    Atypical Frontotemporal Dementia with Parkinsonism Linked to SQSTM1 Mutation A Clinicopathological Case Study

    C. Espinoza Vinces, M. Zelaya Huerta, V. Coca Pueyo, G. Montoya Murillo, A. Patiño García, R. Villino Rodríguez, A. Atorrasagasti Villar, J. Arbizu, M. Riverol (Pamplona, Spain)

    Objective: To describe the clinical, neuroimaging, and neuropathological features of a patient with frontotemporal dementia (FTD) and parkinsonism related to mutation in the SQSTM1 gene.…
  • 2025 International Congress

    Multiscale entropy: a New Oculomotor Measure of PSP.

    C. O'Keeffe, A. Gallagher, J. Inocentes, B. Coe, B. White, D. Brien, D. Munoz, R. Walsh, T. Lynch, C. Fearon (Dublin, Ireland)

    Objective: The objective of this study was investigate whether multiscale entropy, a measure of complexity, when applied to the path of unconstrained eye movements could…
  • 2025 International Congress

    Conjugal Parkinsonism

    CK. Tan (Singapore, Singapore)

    Objective: To report a case of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a couple. Background: Conjugal parkinsonism denotes an entity where…
  • 2025 International Congress

    Wearable Sensor-Based Assessment of Lower Extremity Dystonia in X-linked Dystonia Parkinsonism

    G. Corniani, N. Landra, N. Ganza, S. Begalan, P. Acuna, C. Go, S. Baker, N. Sharma, P. Bonato, C. Stephen (Boston, USA)

    Objective: To develop a sensor-based pipeline to identify lower limb dystonic features in X-linked dystonia parkinsonism (XDP). Background: XDP is a rare neurogenetic combined movement…
  • 2025 International Congress

    Results from the PRIME-UK Randomised Controlled Trial

    K. Lloyd, E. Tenison, C. Mcdonald, S. Haworth, C. Glover, R. Harrison, D. Pendry-Brazier, M. Smith, F. Lithander, A. Cullen, K. Naylor, N. Giles, T. Gabriel, P. Kamnerdsupaphon, A. Nodehi, Y. Ben-Shlomo, EJ. Henderson (Bristol, United Kingdom)

    Objective: To evaluate whether PRIME-Parkinson care increases the ability of people with parkinsonism (PwP) to achieve their personal goals, has a positive impact on health…
  • 2025 International Congress

    Clinical Characteristics of Sporadic Parkinson’s Disease with Negative CSF Alpha-synuclein Seed Amplification Assay

    S. Brooker, J. Pasquini, S. Choi, D. Lafontant, K. Marek, T. Simuni, P. Gonzalez-Latapi, N. Pavese, K. Poston (Chicago, USA)

    Objective: Define clinical characteristics of individuals with sporadic Parkinson’s disease (sPD) enrolled in the Parkinson’s Progression Markers Initiative (PPMI) who have a negative CSF alpha-synuclein…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley